Dispatches from BIO 2016

Drug development in space: how microgravity enables pharma

The SpaceX Dragon spacecraft nears the International Space Station during the CRS-8 mission to deliver experiments and supplies to the International Space Station. (Image credit: NASA)

Eli Lilly is conducting several experiments on the International Space Station (ISS) US National Laboratory over the next year – with several implications for pharma back on Earth.

Related News

Recombinant cell lines provide cost-effective models the early stages of drug development. (Image: iStock/Artsanova)

CrownBio introduces new recombinant cell lines for oncology drug discovery

Enrollment is set to begin late this year. (Image: iStock)

Lilly, Boehringer Ingelheim collaborating on clinical trial

(Image: iStock/ajus)

Purdue Pharma joins health policy research organization

The project is titled “Developing an ethical, sustainable, human sensory neuron cell culture model for use in therapeutic pain research,” or DRGNET. (Image: iStock/bodym)

Metrion: research consortium aiming to reduce animal studies, facilitate new drug development

MR Solution’s – MRS 3017 – 3T cryogen-free MRI preclinical scanner will help advance cancer research with a focus on malignant brain tumors. (Image: MR Solutions)

Preclinical imaging system aids translational research

AAPS highlights key trends at annual meeting

AAPS highlights key trends at annual meeting

(Image: iStock/Pinkypills)

Eli Lilly taps Cogstate as preferred provider


Lilly says manufacturing and pricing swayed revenue rise

With an increasing number of drugs that are ineligible for reimbursement, companies have to better demonstrate their product's value. (Image: iStock/VladimirFLoyd)

Exclusion lists challenging drug developers

Image: iStock/Oleksii Glushenkov

Lilly takes to continuous manufacturing with $40m Irish investment


Big pharma interest in specialty drugs will fuel US market growth says IMS Health

Drug particles, minus excess surfactant, suspended in an injectable solution. (Image: Jonathan Lovell, University at Buffalo)

New technique creates 'nearly pure drug' for injection

Related Products

See more related products